Concepedia

Krzysztof Myszkowski

KM

8

Publications

178

Citations

8

H-Index

2012

Active since

Affiliations

Poznan University of Medical Sciences(Current)

Polish Academy of Sciences

Adam Mickiewicz University in Poznań

Greater Poland Cancer Center

Łukasiewicz Research Network - Wood Technology Institute

Krzysztof Myszkowski is an author at Poznan University of Medical Sciences specializing in medicine, cell biology, and cell death.

ORCID

Top concepts

Publications per year

2012–2021

8

Publications

8

Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV‐3 and A-2780 cancer cells

H. Piotrowska, Krzysztof Myszkowski, Alicja Ziółkowska et al. · Toxicology and Applied Pharmacology · 2012 · 62 citations

, , +12

DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer

H. Piotrowska, Krzysztof Myszkowski, Joanna Abraszek et al. · Biomedicine & Pharmacotherapy · 2014 · 25 citations

, , +10

Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue

H. Piotrowska, Krzysztof Myszkowski, Ryszard Amarowicz et al. · Toxicology in Vitro · 2013 · 21 citations

, , +10

Antifungal, anticancer, and docking studies of colchiceine complexes with monovalent metal cation salts

Joanna Kurek, Patrycja Kwaśniewska‐Sip, Krzysztof Myszkowski et al. · Chemical Biology & Drug Design · 2019 · 18 citations

Cytotoxic, analgesic and anti-inflammatory activity of colchicine and its C-10 sulfur containing derivatives

Joanna Kurek, Krzysztof Myszkowski, I. Okulicz-Kozaryn et al. · Scientific Reports · 2021 · 16 citations · Full text

Rows per page

1–5 of 8